Introduction
Celiac disease occurs in individuals as a reaction to gluten sensitivity. Gluten is a protein that is found in various cereals like Wheat, Barley, and rye. If a patient with celiac disease consumes food containing gluten, this will lead to damage to the mucous membrane of the small intestine.
Tissue transglutaminase (tTG) is an enzyme that is released from cells during inflammation. Measurement of serum anti-tissue transglutaminase (tTG) antibodies is the most common serological test used in screening for celiac disease. To treat celiac disease, doctors advise patients to eat gluten-free food.
Clinical Significance of anti-tTG and Interpretation
Celiac disease has significant clinical importance because it can affect multiple organ systems. If left undiagnosed or untreated, celiac disease may lead to serious complications such as malnutrition, anaemia, osteoporosis, neurological disorders, growth retardation and an increased risk of some intestinal malignancies. Early identification of disease and associated risk factors plays a crucial role in timely diagnosis, disease prevention, and long-term patient management.
The interpretation of genetic and risk-factor analysis in celiac disease requires careful clinical correlation with serological tests, symptoms, and the person’s diet.
Different Diagnostic ways to test for anti-tTG IgA antibody levels
A doctor recommends an anti-tTG IgA antibody test to check for Celiac Disease.
Commonly used methods to detect Anti-tTG IgA antibody levels in laboratories include electrochemiluminescence (ECLIA), immunoturbidimetric method, Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA) and Fluorescent Enzyme Immunoassay (FEIA).
The detection of anti-tTG IgA Antibodies is based on the most advanced Chemiluminescence Immunoassay. It is used for qualitative detection of anti-tTG IgA antibodies in Human Serum or Plasma samples as an aid in recognition and diagnosis of Celiac disease.
Conclusion
Celiac Disease is an autoimmune disorder that is affected by factors such as family history, gluten exposure, infections, and other autoimmune conditions, which contribute to Celiac disease development and progression. Ultimately, Early identification of the disease plays a crucial role in timely diagnosis, disease prevention, and long-term patient management. The interpretation of genetic and risk-factor analysis in celiac disease requires careful clinical correlation with serological tests, symptoms, and the person’s diet.
Explore the Product…
